Triple

T22276661
Position Surface form Disambiguated ID Type / Status
Subject Driehaus Architecture Prize E550624 entity
Predicate notableRecipient P108 FINISHED
Object Allan Greenberg E763993 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Allan Greenberg | Statement: [Driehaus Architecture Prize, notableRecipient, Allan Greenberg]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Allan Greenberg
Context triple: [Driehaus Architecture Prize, notableRecipient, Allan Greenberg]
  • A. Allan Greenberg chosen
    Allan Greenberg is an American architect renowned for reviving and advancing New Classical architecture through his traditionally inspired yet contemporary designs.
  • B. Roger Greenberg
    Roger Greenberg is the neurotic, self-absorbed protagonist of the 2010 Noah Baumbach film "Greenberg," portrayed by Ben Stiller.
  • C. Martin Greenberg
    Martin Greenberg was an American publisher and editor best known for co-founding Gnome Press, which helped popularize early science fiction literature.
  • D. Dan Greenburg
    Dan Greenburg is an American author and humorist best known for his satirical books and children's series such as "The Zack Files."
  • E. Phil Greenberg
    Phil Greenberg is an immunologist and biotech entrepreneur known for pioneering work in cancer immunotherapy and co-founding Juno Therapeutics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e44d538819097c6b8f333af3352 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f14ea8a6688190bcd168670420ec59 completed April 29, 2026, 12:19 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b9e7a4dd08190a45bad821b015ca4 completed May 18, 2026, 11:19 p.m.
Created at: April 16, 2026, 8:40 p.m.